A Phase 1 Study to Evaluate the Safety, Tolerability, PK and PD of SLN124 in Healthy Volunteers

Clinical trial NCT04559971 · COMPLETED

Trial details

NCT number: NCT04559971
Sponsor: Silence Therapeutics plc
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2020-09-03
Primary completion: 2021-03-23
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.